semaglutide sglt2 Frontiers Diabetes Distilled: Keeping kidneys FLOWing

The VSMC GLP-1R is required for semaglutide-mediated reduction in BP in normotensive and hypertensive mice

Week 1-4: Starting dose (2.5mg) Weekly dose : 2.5mg Why this dose : Introduces GLP-1 effect Minimal side effects Tests tolerance Begins appetite suppression What to expect : Mild appetite reduction (20-30%) Slight nausea first few days (30% of users) Weight loss: 2-4 lbs (mostly water) Energy may dip initially Common mistake : Thinking 2.5mg is "too low" and skipping to 5mg

If you know when to expect symptoms, you can prepare

Adhikari, A

Beyond clinical trial data, many patients report feeling tired or experiencing low energy when starting or adjusting doses of these medications

It is a structured way of eating your meals to offer better support to those who are taking GLP-1 medications